LTS Lohmann Therapy Systems, Corp.
Contract developer and manufacturer of non-invasive drug delivery systems and combination products. Offers end-to-end CDMO services for transdermal patches, topical patches, oral thin films, dissolvable microneedle patches and on-body delivery systems, including API evaluation, formulation development, prototyping, clinical trial supply, scale-up and commercial manufacture across multiple global sites. Maintains dedicated R&D laboratories for permeation testing and analytical support and reports site-level sustainability and quality management commitments.
Industries
N/A
Nr. of Employees
medium (51-250)
Products
Transdermal therapeutic systems (patches)
Transdermal patch platforms for systemic and local delivery of active substances with scalable production capability.
Oral thin films
Orally dissolving thin film formulations for rapid or convenient delivery of active ingredients via the buccal/oral mucosa.
Dissolvable microneedle (microarray) patches
Microneedle patch products designed for intradermal delivery with potential applications in vaccines, biologics and small molecules.
On-body delivery systems and wearable injectors
On-body delivery platforms supporting dose volumes from point-of-care small-volume loading to larger pre-filled configurations, designed for programmable infusion and patient-centred use.
Accutip Microneedle Array Patches
Proprietary dissolvable microneedle array patch platform designed to deliver drugs or vaccines locally through the skin, featuring configurable release options and needle dimensions.
CDMO services
Local contract development and manufacturing services for non-invasive drug delivery systems supporting pharma partners from bench to market.
Transdermal therapeutic systems (patches)
Transdermal patch platforms for systemic and local delivery of active substances with scalable production capability.
Oral thin films
Orally dissolving thin film formulations for rapid or convenient delivery of active ingredients via the buccal/oral mucosa.
Dissolvable microneedle (microarray) patches
Microneedle patch products designed for intradermal delivery with potential applications in vaccines, biologics and small molecules.
On-body delivery systems and wearable injectors
On-body delivery platforms supporting dose volumes from point-of-care small-volume loading to larger pre-filled configurations, designed for programmable infusion and patient-centred use.
Accutip Microneedle Array Patches
Proprietary dissolvable microneedle array patch platform designed to deliver drugs or vaccines locally through the skin, featuring configurable release options and needle dimensions.
CDMO services
Local contract development and manufacturing services for non-invasive drug delivery systems supporting pharma partners from bench to market.
Services
Integrated services including API evaluation, feasibility studies, formulation development, prototyping, clinical trial supply, scale-up and commercial manufacture for transdermal, topical, oral film, microneedle and device products.
IVPT and permeation studies designed and executed according to OECD, FDA and EMA guidance, including GMP-certified IVPT and analytical workflows to support formulation optimisation and regulatory submissions.
Development and manufacture of drug-device combination products, including on-body delivery systems, wearable injectors and support for high-viscosity formulations and sterile filling workflows.
Integrated services including API evaluation, feasibility studies, formulation development, prototyping, clinical trial supply, scale-up and commercial manufacture for transdermal, topical, oral film, microneedle and device products.
IVPT and permeation studies designed and executed according to OECD, FDA and EMA guidance, including GMP-certified IVPT and analytical workflows to support formulation optimisation and regulatory submissions.
Development and manufacture of drug-device combination products, including on-body delivery systems, wearable injectors and support for high-viscosity formulations and sterile filling workflows.
Expertise Areas
- Transdermal drug delivery
- Topical patch systems and hot-melt adhesives
- Oral thin film development
- Dissolvable microneedle (microarray) patches
Key Technologies
- Transdermal therapeutic systems (patch coating and conversion)
- Hot-melt adhesive topical patch technology
- Oral thin film manufacturing
- Dissolvable microarray (microneedle) patches
News & Updates
Press release announcing acquisition to expand global CDMO manufacturing capacity.
Coverage of a site visit highlighting company manufacturing and community engagement.
Announcement of strategic cooperation to expand global manufacturing and accelerate market expansion.
Announcement of the company’s commitment to set science-based climate targets and alignment with SBTi methodology.
Awarded funding for projects related to patch technologies through a public health competition.
Grant awarded to support women’s health initiatives in low- and middle-income countries.
Press release announcing acquisition to expand global CDMO manufacturing capacity.
Coverage of a site visit highlighting company manufacturing and community engagement.
Announcement of strategic cooperation to expand global manufacturing and accelerate market expansion.
Announcement of the company’s commitment to set science-based climate targets and alignment with SBTi methodology.
Awarded funding for projects related to patch technologies through a public health competition.
Grant awarded to support women’s health initiatives in low- and middle-income countries.